Cytotoxicity and antimicrobial susceptibility of Clostridium difficile isolated from hospitalized children with acute diarrhea

Anaerobe

Volumn 10, Issue 3, 2004, Pages 171-177

  Ferreira, Claudia Elisa Alves ^a   Nakano, Viviane ^a   Avila Campos, Mario Julio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimicrobial susceptibility; Clostridium difficile; Cytotoxicity; Diarrhea

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; CEFALEXIN; CEFOXITIN; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; METRONIDAZOLE; OXACILLIN; PENICILLIN G; TRIMETREXATE;

ACUTE DIARRHEA; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM CLOSTRIDIOFORME; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INNOCUUM; CLOSTRIDIUM LIMOSUM; CLOSTRIDIUM PARAPUTRIFICUM; CLOSTRIDIUM RAMOSUM; CLOSTRIDIUM SEPTICUM; CLOSTRIDIUM SPHENOIDES; CONTROLLED STUDY; CYTOTOXICITY; FECES ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MALE; MONKEY; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

CLOSTRIDIA; CLOSTRIDIUM; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM CLOSTRIDIOFORME; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INNOCUUM; CLOSTRIDIUM LIMOSUM; CLOSTRIDIUM PARAPUTRIFICUM; CLOSTRIDIUM RAMOSUM; CLOSTRIDIUM SEPTICUM; CLOSTRIDIUM SP.; CLOSTRIDIUM SPHENOIDES;

EID: 2942702111     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2004.02.003     Document Type: Article

References (25)

1. Albert M.J., Faruque A.S.G., Faruque S.M., Sac R.B., Mahalanabis D. Case control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microb. 37:1999;3458-3464
2. Falk P.G., Hooper L.V., Midtvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem. what we know and need to know from gnotobiology Microb Mol Biol Rev. 62:1998;1157-1170
3. Holdeman L.V., Moore W.E.C. Anaerobe laboratory manual. 4th ed:1977;Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, USA
4. Delost M.D. Introduction to diagnostic microbiology. 1st ed:1997;Mosby, St Louis, MO, USA
5. Karasawa T., Nojiri T., Hayashi Y., Maegawa T., Yamakawa K., Wang X.M., Nakamura S. Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction. presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals J Gastr. 34:1999;41-45
6. Bartlett J.G. Clostridium difficile. history of its role as an enteric pathogen and the current state of knowledge about the organism Clin Infect Dis. 18:1994;5265-5672
7. Lyerly D.M., Saum K.E., MacDonald D.K., Wilkins T.D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun. 47:1985;349-352
8. Knoop F.C., Owens M., Crocker I.C. Clostridium difficile. clinical disease and diagnosis Clin Microbiol Rev. 6:1993;251-265
9. Peterson L.R., Kelly P.J., Nordbrock H.A. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis. 15:1996;330-336
10. McMillin D.E., Muldrow L.L., Leggette S.J. Simultaneous detection of toxin A and toxin B genetic determinants of Clostridium difficile using the multiplex polymerase chain reaction. Can J Microbiol. 38:1992;81-83
11. Freeman J., Wilcox M.H. Antibiotics and Clostridium difficile. Microb Infect. 1:1999;377-384
12. Wust J., Hardegger U. Studies on the resistance of Clostridium difficile to antimicrobial agents. Zentralbl Bakteriol Hyg. 267:1988;383-394
13. George W.L., Sutter V.L., Citron D., Finegold S.M. Selective and differential medium for isolation of C. difficile. J Clin Microbiol. 9:1979;214-219
14. Sutter V.L., Barry A.L., Wilkins T.D., Zabransky R.J. Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother. 16:1979;495-502
15. Kato H., Kato N., Watanabe K., Yamamoto T., Suzuki K., Ishigo S., Kunihiro S., Nakamura I., Killgore G.E., Nakamura S. Analysis of C. difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan. J Clin Microb. 39:2001;1391-1395
16. Lee K., Yong D., Yum J., Sohn Y.S., Chong Y. Modification of cycloserine cefoxitin fructose agar to suppress growth of yeasts from stool specimens. Anaerobe. 6:2000;269-271
17. Van der Vorm E.R. Gas gangrene in an immunocompromised girl due to a Clostridium ramosum infection. Clin Infect Dis. 28:1999;923-924
18. Soyletir G., Eskiturk A., Kilie G., Kortn V., Tozun N. Clostridium difficile acquisition rate and its role in nosocomial diarrhoea at a university hospital in Turkey. Eur J Epidemiol. 12:1996;391-394
19. Garcia L.B., Uzeda M. Ocorrência de Clostridium difficile nas fezes de crianças do Rio de Janeiro, RJ. Rev Inst Med Trop S. Paulo. 30:1988;419-423
20. Bressane M.A., Durigon E.L., Avila-Campos M.J. Prevalence of the Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in immunodeficient children. Anaerobe. 7:2001;277-281
21. Lerm M., Schmidt G., Aktories K. Bacterial protein toxins targeting Rho GTPases. FEMS Microbiol Lett. 188:2000;1-6
22. Ooi W., Levine H.G., LaMont J.T., Clark R.A. Inactivation of Clostridium difficile cytotoxin by the neutrophil myeloperoxidase system. J Infect Dis. 149:1984;215-219
23. Wexler H.M., Molitoris D., Finelgold S.M. In vitro activity of gatifloxacin against 238 strains of anaerobic bacteria. Anaerobe. 7:2001;285-289
24. Hecht D.W., Vedantam G., Osmolski J.R. Antibiotic resistance among anaerobes. what does it mean? Anaerobe. 5:1999;421-429
25. Kink J.A., Williams J.A. Antibodies to recombinant Clostridium difficile toxins A and B are effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect Immun. 66:1998;2018-2025